BGM Stock Analysis
BG
Uncovered
Qilian International Holding Group Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Qilian International Holding Group Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Jiuquan, Gansu and currently employs 298 full-time employees. The company went IPO on 2021-01-12. Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.